Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Page 1
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
de Jong CMM, Visser C, Bemelmans RHH, Boersma WG, van den Borst B, Burggraaf JLI, Cannegieter SC, Ten Cate-Hoek AJ, Croles FN, Faber HJ, Faber LM, Hellemons ME, Hessels LM, Huisman MV, Kamphuisen PW, Koster SCE, Kroft LJM, van der Lee I, Leentjens J, Meijer K, Ninaber MK, Sondermeijer BM, Stads S, Vonk Noordegraaf A, Winckers K, Kruip MJHA, Klok FA; Dutch COVID & Thrombosis Coalition investigators. de Jong CMM, et al. Among authors: kamphuisen pw. Eur Respir J. 2023 Apr 20;61(4):2300171. doi: 10.1183/13993003.00171-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 37080574 Free PMC article.
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE https://bit.ly/3IjvWL3 The inc …
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE i …
Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
van Es J, Cheung YW, van Es N, Klok FA, Dronkers CEA, Ten Wolde M, Kruip MJHA, Huisman MV, Meijer K, Kamphuisen PW, Gerdes VEA, Middeldorp S. van Es J, et al. Among authors: kamphuisen pw. Thromb Res. 2020 Mar;187:125-130. doi: 10.1016/j.thromres.2020.01.010. Epub 2020 Jan 20. Thromb Res. 2020. PMID: 31986475 Free article.
Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
Bauersachs R, Lee AYY, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, Khorana AA; CATCH Investigators. Bauersachs R, et al. Among authors: kamphuisen pw. Thromb Haemost. 2018 May;118(5):914-921. doi: 10.1055/s-0038-1641150. Epub 2018 Apr 4. Thromb Haemost. 2018. PMID: 29618162 Clinical Trial.
CONCLUSION: RI in patients with cancer-associated thrombosis on anticoagulation was associated with a statistically significant increase in recurrent VTE and major bleeding, but no significant increase in CRB or mortality. No differences were observed between long-term tin …
CONCLUSION: RI in patients with cancer-associated thrombosis on anticoagulation was associated with a statistically significant increase in …
Long-term arterial complications of chemotherapy in patients with cancer.
Svilaas T, Lefrandt JD, Gietema JA, Kamphuisen PW. Svilaas T, et al. Among authors: kamphuisen pw. Thromb Res. 2016 Apr;140 Suppl 1:S109-18. doi: 10.1016/S0049-3848(16)30109-8. Thromb Res. 2016. PMID: 27067963 Review.
Because these conditions can result in a high degree of morbidity and mortality, understanding how to improve the prevention, recognition, and treatment of vascular disease is an important medical priority in the care for cancer survivors. This review will focus on the long-te …
Because these conditions can result in a high degree of morbidity and mortality, understanding how to improve the prevention, recognition, a …
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.
Bleker SM, van Es N, Kleinjan A, Büller HR, Kamphuisen PW, Aggarwal A, Beyer-Westendorf J, Camporese G, Cosmi B, Gary T, Ghirarduzzi A, Kaasjager K, Lerede T, Marschang P, Meijer K, Otten HM, Porreca E, Righini M, Verhamme P, van Wissen S, Di Nisio M. Bleker SM, et al. Among authors: kamphuisen pw. J Thromb Haemost. 2016 May;14(5):973-81. doi: 10.1111/jth.13291. Epub 2016 Apr 4. J Thromb Haemost. 2016. PMID: 26866515 Free article.
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
van Es N, Di Nisio M, Bleker SM, Segers A, Mercuri MF, Schwocho L, Kakkar A, Weitz JI, Beyer-Westendorf J, Boda Z, Carrier M, Chlumsky J, Décousus H, Garcia D, Gibbs H, Kamphuisen PW, Monreal M, Ockelford P, Pabinger I, Verhamme P, Grosso MA, Büller HR, Raskob GE. van Es N, et al. Among authors: kamphuisen pw. Thromb Haemost. 2015 Nov 25;114(6):1268-76. doi: 10.1160/TH15-06-0452. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26271200 Clinical Trial.
The evaluation beyond six months will fill the current gap in the evidence base for the long-term treatment of these patients. Based on the observation that the risk of recurrent VTE in patients with active cancer is similar to that in those with a history of cancer, the H …
The evaluation beyond six months will fill the current gap in the evidence base for the long-term treatment of these patients. Based …
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world. Actual use of low-molecular-weight heparin in cancer.
Kleinjan A, Hutten BA, Di Nisio M, Büller HR, Kamphuisen PW. Kleinjan A, et al. Among authors: kamphuisen pw. Neth J Med. 2014 Nov;72(9):467-72. Neth J Med. 2014. PMID: 25431392 Free article.
BACKGROUND: Since 2004, guidelines recommend long-term treatment with low-molecular-weight heparin (LMWH) in patients with cancer and pulmonary embolism (PE). ...RESULTS: 600 cancer patients with PE were matched to 1200 patients with PE without cancer. Long-term LMW …
BACKGROUND: Since 2004, guidelines recommend long-term treatment with low-molecular-weight heparin (LMWH) in patients with cancer and …
Gaining experience with the NOACs.
Kamphuisen PW. Kamphuisen PW. Blood. 2014 Aug 7;124(6):836. doi: 10.1182/blood-2014-06-578948. Blood. 2014. PMID: 25104864 Free PMC article.
In this issue of Blood, Beyer-Westendorf et al analyzed the safety of long-term treatment with the novel oral anticoagulant (NOAC) factor Xa inhibitor, rivaroxaban, in a large registry of patients from their clinical practice with either venous thromboembolism (VTE) or atr …
In this issue of Blood, Beyer-Westendorf et al analyzed the safety of long-term treatment with the novel oral anticoagulant (NOAC) fa …
Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
Klein Hesselink EN, Klein Hesselink MS, de Bock GH, Gansevoort RT, Bakker SJ, Vredeveld EJ, van der Horst-Schrivers AN, van der Horst IC, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD. Klein Hesselink EN, et al. Among authors: kamphuisen pw. J Clin Oncol. 2013 Nov 10;31(32):4046-53. doi: 10.1200/JCO.2013.49.1043. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101052
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.
van Es J, den Exter PL, Kaptein AA, Andela CD, Erkens PM, Klok FA, Douma RA, Mos IC, Cohn DM, Kamphuisen PW, Huisman MV, Middeldorp S. van Es J, et al. Among authors: kamphuisen pw. Thromb Res. 2013 Nov;132(5):500-5. doi: 10.1016/j.thromres.2013.06.016. Epub 2013 Oct 3. Thromb Res. 2013. PMID: 24090607
Scores on the SF-35 and PEmb-QoL were used to evaluate QoL in the short-term and long-term clinical course of patients with acute PE. In addition, we examined correlations between PEmb-QoL scores and clinical patient characteristics. ...Comparing intermediately asse …
Scores on the SF-35 and PEmb-QoL were used to evaluate QoL in the short-term and long-term clinical course of patients with ac …
18 results